University Of Texas Medical Branch At Galveston
University Of Texas Medical Branch At Galveston is recorded as a service provider in 2 clinical trials. Explore its recorded services, study phases and therapeutic areas, with trial-level operational learnings where available.
Clinical trial experience
Showing 2 of 2 trials · Latest update first
MT-7117-A-302 Study: A Phase 3, Multicenter, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate Efficacy, Safety, and Tolerability of MT-7117 in Adults and Adolescents with Erythropoietic Protoporphyria or X-Linked Protoporphyria
Sponsor Tanabe Pharma America Inc.
- Start (EU)
- Latest update
- Estimated end
A Phase 3, Multicenter, Open-label, Long-term, Extension Study to Evaluate Safety and Tolerability of Oral Dersimelagon (MT-7117) in Subjects with Erythropoietic Protoporphyria (EPP) or X-Linked Protoporphyria (XLP)
Sponsor Tanabe Pharma America Inc.
- Start (EU)
- Latest update
- Estimated end
Questions about this trial experience
What services are recorded for University Of Texas Medical Branch At Galveston?
The 2026-10-09 snapshot links University Of Texas Medical Branch At Galveston to 2 distinct CTIS trials. Recorded services include Laboratory services, porphyrin testing. These are study-specific roles, not a complete or independently verified capability catalogue.
Which therapeutic areas and study phases are recorded for University Of Texas Medical Branch At Galveston?
The most frequently recorded therapeutic areas are Dermatology, Genetic and Congenital Disorders, Metabolic Disorders. Recorded phases include Phase 3. Use the filters to inspect the supporting studies; missing tags are not evidence of absent experience.
In which countries are trials linked to University Of Texas Medical Branch At Galveston conducted?
The linked trials record locations in 10 countries, including Bulgaria, Czechia, Spain, France, Italy. These are trial locations, not confirmed office locations or countries where University Of Texas Medical Branch At Galveston delivered services.
What can this page tell me about University Of Texas Medical Branch At Galveston's trial experience?
Browse 2 distinct trials with recorded roles, sponsor names, available study dates and links to CTIS source records. No trial-level operational findings are recorded in this snapshot. Trial counts and findings do not measure the provider’s performance or establish responsibility for study outcomes.
About this data & company names
One current approved profile per CTIS trial. Services reflect recorded roles, not a complete capability catalogue or a performance ranking. Missing tags mean the information was not recorded. Country tags describe trial locations, not the provider’s service territory.
Start is the reported EU start date; latest update is the CTIS publication date; estimated end is the reported global estimate, which may be in the past. Missing dates are shown as “Not reported”. Operational learnings describe the trial as a whole and do not establish the provider’s responsibility.
Clear service synonyms are grouped; otherwise the source label is retained. Service tags show the recorded roles for each trial. This page groups 1 recorded name variant under University Of Texas Medical Branch At Galveston. Legacy brands remain separate unless explicitly matched in the name registry.
View recorded company names
- University Of Texas Medical Branch At Galveston